Preventative treatment of chronic migraine will continue to evolve in short-term with anti-CGRP mAbs… GlobalData Jul 8, 2024 The positive results from the study indicate that the treatment for chronic disease prevention will continue to evolve in the…
IAVI, Merck KGaA and Serum Institute partner to develop COVID-19 mAbs EP News Bureau Oct 22, 2020 The partnership aims to ensure access to a class of innovative therapies that have, to date, been out of reach in low- and…
